Clinical Trials on Major Depressive Disorder, Bipolar I and Bipolar II in Italy

Total 64 results

IRCCS San Raffaele
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Recruiting

Development of a Software Tool, Using Artificial Intelligence, That Integrates Clinical, Biological, Genetic and Imaging Data to Predict Diagnosis and Outcome of Depressed Patients in Order to Enhance Prognosis and Limiting Healthcare Costs.

Bipolar Disorder | Unipolar Depression

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) (RONIN)

Major Depressive Disorder | Bipolar Affective Disorder, Currently Depressed, Moderate

Italy
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY BD)

Bipolar Depression

Austria, Germany, Italy, Spain, United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Mental Coaching and Counseling for Bipolar Patients: Dealing With Moments of Crisis in Times of COVID-19.

To Determine the Incidence of Depression in Subjects Affected by Bipolar Disorder

Italy
Ospedale San Raffaele
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Ministry of Health...

Recruiting

Improving Health Care in Major Depressive Disorder (DepType)

Major Depressive Disorder

Italy
Azienda Socio Sanitaria Territoriale degli Spedali...
IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli

Recruiting

Clinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive Disorder (PANDORA)

Major Depressive Disorder

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
ASST Santi Paolo e Carlo; Azienda Ospedaliera SS. Antonio e Biagio e Cesare... and other collaborators

Completed

Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders (DYSBIP)

Bipolar Disorder

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
University of Trieste; IRCCS Fondazione Stella Maris; CNR Institute of Neuroscience...

Recruiting

Integrins and Protocadherins in Glutamatergic Circuits: Identification of Common Signaling Pathways and Molecular Targets in Anxiety and Major Depressive Disorders (GAPsy) (GAPsy)

Healthy | Depression, Anxiety

Italy
Azienda ULSS di Verona e Provincia
Universita di Verona; FONDAZIONE CARIVERONA

Completed

Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses (PHYSICO-DSM-VR)

Psychotic Disorders | Bipolar Disorders

Italy
Azienda Socio Sanitaria Territoriale degli Spedali...

Not yet recruiting

A Trial of Functional Remediation in Patients With Bipolar Disorder

Bipolar Disorder

Italy
Fidia Farmaceutici s.p.a.

Recruiting

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

Major Depressive Disorder

Italy
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY MDD)

Major Depressive Disorder | Treatment Resistant Depression

Austria, Germany, Italy, Spain, United Kingdom
University of Campania "Luigi Vanvitelli"
University of Pisa; University of Bologna; University of Roma La Sapienza; Universita... and other collaborators

Recruiting

Psychoeducational Intervention for Families With a Member Affected by Major Depression

Depressive Disorder, Major

Italy
Aziende Chimiche Riunite Angelini Francesco S.p.A
Mediolanum Cardio Research

Terminated

SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)

Bipolar Disorder

Italy
Istituto Auxologico Italiano

Recruiting

Potential Predictive Biological Markers of Major Depression Response to Citalopram Therapy in Anorexia Nervosa. (ANCITA)

Anorexia Nervosa

Italy
Institute of Neuroscience, Florence, Italy

Completed

Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression

Major Depression

Italy
H. Lundbeck A/S

Completed

Study With Vortioxetine on Emotional Functioning in Patients With Depression (COMPLETE)

Major Depressive Disorder

France, Italy, Lithuania, Spain
Alkermes, Inc.

Completed

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Schizophrenia | Schizophreniform Disorder | Bipolar I Disorder

United States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
Azienda Ospedaliero-Universitaria Careggi

Recruiting

Sumor as Adjuvant Therapy in Treatment-resistant Major Depression (SUSCA)

Major Depressive Disorder

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Boosting Psychotherapy Effects by Means of Transcranial Direct Current Stimulation (PSYCHOBOOST)

Major Depressive Disorder

Italy
IRCCS San Raffaele

Recruiting

Inflammatory Control of Antidepressant Efficacy: a Pharmaco-epigenetic Approach

Mood Disorders | Major Depressive Disorder

Italy
Azienda Ospedaliera Universitaria Integrata Verona
University of Catania

Completed

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment (VESPA)

Major Depressive Disorder

Italy
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Bipolar Disorder | Bipolar Mania

United States, Chile, Guatemala, Taiwan, Spain, Italy, France, Hong Kong, India, Mexico, Venezuela, Russian Federation, Germany
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

Trazodone Once a Day in Major Depression Disorder

Major Depressive Disorder

Austria, Czech Republic, Italy, Romania, Slovakia, Spain
AstraZeneca

Completed

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients (RUBY)

Major Depressive Disorder | Treatment Resistant Depression

Bulgaria, Italy, United Kingdom, Germany, Hungary, Romania, Austria, Belgium, Denmark, Portugal, Slovakia, Australia, Spain
AstraZeneca

Completed

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Bipolar I Disorder

United States, Sweden, Bulgaria, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Czech Republic, Hungary, Finland, Norway, Australia, Belgium
Eli Lilly and Company

Completed

A Study in Prevention of Re-emergence of Depression Symptoms

Major Depressive Disorder

United States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

Bipolar Disorder Mania

Italy, Poland, Russian Federation, Turkey, South Africa, Austria, Hungary, France, Spain, Czech Republic, Germany, Greece, Romania
AstraZeneca

Completed

A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD) (Improve)

Major Depressive Disorder | MDD

Italy
H. Lundbeck A/S

Completed

Real-life Effectiveness of Vortioxetine in Depression (RELIEVE)

Major Depressive Disorder

United States, Canada, France, Italy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Ziprasidone And Olanzapine's Outcomes In Mania (ZOOM)

Acute Mania | Bipolar Disorder, Manic

Turkey, Italy, Germany, Greece, Spain
Eli Lilly and Company

Completed

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

Major Depressive Disorder

Denmark, France, Greece, Hungary, Italy, Netherlands, Romania, Slovenia, Spain, Sweden, Turkey
AstraZeneca

Completed

IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder (IBIS)

Schizophrenia | Bipolar Disorder

Italy
Janssen Research & Development, LLC

Terminated

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

Depressive Disorder, Major

United States, Spain, Italy, United Kingdom
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom
H. Lundbeck A/S
ICON plc

Completed

Vortioxetine in Patients With Depression and Early Dementia (MEMORY)

Dementia | Major Depressive Disorder

Korea, Republic of, Spain, Poland, Estonia, France, Italy
AstraZeneca

Completed

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

Acute Bipolar Manic Episode

Croatia, Italy, Turkey, United Kingdom, Germany, Belgium, Finland, Denmark
IRCCS San Raffaele

Recruiting

Immune Activation, Neural Plasticity and Depression

Mood Disorders | Sleep Deprivation | Major Depressive Disorder

Italy
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Study of Aripiprazole in Patients With Bipolar I Disorder

Bipolar Disorder

France, Portugal, Spain, Italy, Germany, South Africa, United Kingdom, United States, Russian Federation, Poland, Czech Republic, Hungary, Netherlands, Estonia, Australia, Bulgaria, Switzerland
H. Lundbeck A/S

Terminated

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Depressive Disorder, Major

United States, Korea, Republic of, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Latvia, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Mexico, South Africa, United Kingdom
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Alkermes, Inc.

Completed

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Schizophrenia | Bipolar I Disorder | Schizophreniform Disorders

United States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
Janssen Research & Development, LLC

Recruiting

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT)

Depressive Disorder, Major

United States, Korea, Republic of, Taiwan, Slovakia, Spain, Bulgaria, Poland, Belgium, Argentina, Czechia, Hungary, South Africa, Sweden, Italy, France, Australia, China, Brazil, Portugal
GlaxoSmithKline

Completed

Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Belgium, Peru, Argentina, Chile, Costa Rica, Slovakia, Italy, Germany, Poland, Spain, Sweden
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Major Depressive Disorder

France, Italy, Russian Federation, South Africa
University of Cagliari
Alessandra Perra

Completed

An E-health Psychoeducation for People With Bipolar Disorders

Bipolar Disorder | COVID-19 Pandemic | Psychoeducation

Italy
Janssen Research & Development, LLC

Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

Depressive Disorder, Major

United States, France, Italy, Spain, Hungary, Belgium, Brazil, Bulgaria, Poland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Depressive Disorder, Major

United States, France, Germany, Italy, Russian Federation, Sweden

Clinical Trials on Major Depressive Disorder, Bipolar I and Bipolar II in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations